260 related articles for article (PubMed ID: 26942290)
41. Encephalocraniocutaneous lipomatosis: complete neuroradiologic evaluation and follow-up of two cases.
Parazzini C; Triulzi F; Russo G; Mastrangelo M; Scotti G
AJNR Am J Neuroradiol; 1999 Jan; 20(1):173-6. PubMed ID: 9974077
[TBL] [Abstract][Full Text] [Related]
42. Encephalocraniocutaneous lipomatosis with neurocutaneous melanosis.
Jain P; Chakrabarty B; Kumar A; Gupta N; Kabra M; Gulati S
J Child Neurol; 2014 Jun; 29(6):846-9. PubMed ID: 23620525
[TBL] [Abstract][Full Text] [Related]
43. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract][Full Text] [Related]
44. Encephalocraniocutaneous lipomatosis (Fishman syndrome): a rare neurocutaneous syndrome.
Amor DJ; Kornberg AJ; Smith LJ
J Paediatr Child Health; 2000 Dec; 36(6):603-5. PubMed ID: 11115042
[TBL] [Abstract][Full Text] [Related]
45. Expanding the phenotype of oculoectodermal syndrome: possible relationship to encephalocraniocutaneous lipomatosis.
Ardinger HH; Horii KA; Begleiter ML
Am J Med Genet A; 2007 Dec; 143A(24):2959-62. PubMed ID: 17963257
[TBL] [Abstract][Full Text] [Related]
46. Encephalocraniocutaneous lipomatosis with Wilms' tumor.
Damar Ç; Yaman A; Ali İkidağ M; Pekpak E; Olgaç A
Pediatr Int; 2017 Jul; 59(7):835-836. PubMed ID: 28612492
[No Abstract] [Full Text] [Related]
47. Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene.
Legius E; Wu R; Eyssen M; Marynen P; Fryns JP; Cassiman JJ
J Med Genet; 1995 Apr; 32(4):316-9. PubMed ID: 7643367
[TBL] [Abstract][Full Text] [Related]
48. A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL.
Yang K; Wang J; Kanwar N; Villani A; Ajani O; Fleming A; Patil V; Mamatjan Y; Wei Q; Malkin D; Shlien A; Zadeh G; Provias J
Brain Tumor Pathol; 2022 Oct; 39(4):225-231. PubMed ID: 35668302
[TBL] [Abstract][Full Text] [Related]
49. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas?
Valera ET; Brassesco MS; Scrideli CA; de Castro Barros MV; Santos AC; Oliveira RS; Machado HR; Tone LG
Childs Nerv Syst; 2012 Jan; 28(1):19-22. PubMed ID: 21983849
[TBL] [Abstract][Full Text] [Related]
50. Activating FGFR1 Mutations in Sporadic Pheochromocytomas.
Welander J; Łysiak M; Brauckhoff M; Brunaud L; Söderkvist P; Gimm O
World J Surg; 2018 Feb; 42(2):482-489. PubMed ID: 29159601
[TBL] [Abstract][Full Text] [Related]
51. Encephalocraniocutaneous lipomatosis: clinical spectrum of systemic involvement.
Sofiatti A; Cirto AG; Arnone M; Romiti R; Santi C; Leite C; Sotto M
Pediatr Dermatol; 2006; 23(1):27-30. PubMed ID: 16445407
[TBL] [Abstract][Full Text] [Related]
52. Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes.
Schmidt J; Kaulfuß S; Ott H; Gaubert M; Reintjes N; Bremmer F; Dreha-Kulaczewski S; Stroebel P; Yigit G; Wollnik B
Hum Genet; 2024 Feb; 143(2):159-168. PubMed ID: 38265560
[TBL] [Abstract][Full Text] [Related]
53. Fibrous Meningioma in a Patient with Encephalocraniocutaneous Lipomatosis: A Rare Case with Unique Features.
Al Qawasmeh M; Aldabbour B; Alhayek K; El-Salem K
Int Med Case Rep J; 2020; 13():347-351. PubMed ID: 32884367
[TBL] [Abstract][Full Text] [Related]
54. PIK3CA activating mutations in facial infiltrating lipomatosis.
Maclellan RA; Luks VL; Vivero MP; Mulliken JB; Zurakowski D; Padwa BL; Warman ML; Greene AK; Kurek KC
Plast Reconstr Surg; 2014 Jan; 133(1):12e-19e. PubMed ID: 24374682
[TBL] [Abstract][Full Text] [Related]
55. Oculocerebrocutaneous and encephalocraniocutaneous lipomatosis syndromes: blind men and an elephant or separate syndromes?
Hunter AG
Am J Med Genet A; 2006 Apr; 140(7):709-26. PubMed ID: 16523517
[TBL] [Abstract][Full Text] [Related]
56. Eye and appearance characteristics of encephalocraniocutaneous lipomatosis.
Tian Y; Wang Y; Gao X; Zhang Y; Ju Y
Eye (Lond); 2019 Feb; 33(2):328-331. PubMed ID: 30250235
[No Abstract] [Full Text] [Related]
57. Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review.
Pavanello M; Piro L; Roggero A; Rossi A; Cataldi M; Piatelli G
Childs Nerv Syst; 2024 Apr; 40(4):1251-1258. PubMed ID: 38217730
[TBL] [Abstract][Full Text] [Related]
58. [Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral ocular damage].
López Sousa M; Varela Iglesias J; Bouzón Alejandro M; Lojo Rodríguez M; Pérez Muñuzuri A; Fernández Lorenzo JR
An Pediatr (Barc); 2007 Jun; 66(6):619-21. PubMed ID: 17583626
[TBL] [Abstract][Full Text] [Related]
59. Encephalocraniocutaneous lipomatosis with calvarial exostosis - Case report and review of literature.
Thakur S; Thakur V; Sood RG; Thakur CS; Khanna S
Indian J Radiol Imaging; 2013 Oct; 23(4):333-6. PubMed ID: 24604937
[TBL] [Abstract][Full Text] [Related]
60. Toward clinical and molecular dissection of frontonasal dysplasia with facial skin polyps: From Pai syndrome to differential diagnosis through a series of 27 patients.
Lehalle D; Bruel AL; Vitobello A; Denommé-Pichon AS; Duffourd Y; Assoum M; Amiel J; Baujat G; Bessieres B; Bigoni S; Burglen L; Captier G; Dard R; Edery P; Fortunato F; Geneviève D; Goldenberg A; Guibaud L; Héron D; Holder-Espinasse M; Lederer D; Lopez Grondona F; Grotto S; Marlin S; Nadeau G; Picard A; Rossi M; Roume J; Sanlaville D; Saugier-Veber P; Triau S; Valenzuela Palafoll MI; Vanlerberghe C; Van Maldergem L; Vezain M; Vincent-Delorme C; Zivi E; Thevenon J; Vabres P; Thauvin-Robinet C; Callier P; Faivre L
Am J Med Genet A; 2022 Jul; 188(7):2036-2047. PubMed ID: 35445792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
